Mumbai, July 17 (IANS) Domestic equity markets traded higher in the morning session on Friday, with benchmark indices gaining around half a per cent each despite weak global cues, led by buying in IT and auto stocks.In early trade, Sensex climbed 363 points or 0.47 per cent to 77,550, while Nifty advanced 100 points or 0.43 per cent to 24,176.Sectorally, IT stocks led the gains, with the Nifty IT index surging nearly 2 per cent, followed by Nifty Auto, which rose 0.83 per cent, and Nifty Private…
Latest Cipla News & Updates
Mumbai, July 16 (IANS) Indian stock markets ended flat on Thursday as investors remained cautious amid geopolitical uncertainties, fluctuating crude oil prices and weak Asian market trends, while financial stocks dragged the benchmarks lower.Sensex settled at 77,186.87, up 1.44 points, while Nifty ended 5.75 points or 0.02 per cent lower at 24,072.75.During the intraday trade, the 30-share index jumped as much as 0.51 per cent or 394 points to 77,579.69 from the previous close, while touching an…
Mumbai, June 22 (IANS) Indian equity benchmarks closed in positive territory on Monday, supported by strong buying in information technology and pharmaceutical stocks, while easing crude oil prices further boosted investor sentiment.The Sensex gained 291.17 points, or 0.38 per cent, to settle at 77,094.07. The Nifty also ended higher, rising 90 points, or 0.37 per cent, to close at 24,102.90.Commenting on Nifty technical outlook, experts said that the 24,200 level continues to act as the immedia…
Mumbai, June 4 (IANS) Domestic equity markets opened lower on Thursday, tracking weak global cues amid geopolitical uncertainty in West Asia and selling pressure across the US and Asian equities.Sensex opened at 73,935.83, down 0.55 per cent or 410 points, while Nifty fell over 100 points or 0.5 per cent.Sectoral indices, Nifty Realty declined 0.67 per cent, Nifty IT was down 0.53 per cent. Similarly, pharma and healthcare indices decreased by up to 0.5 per cent.In contrast, Nifty Consumer Durab…
Mumbai, May 13 (IANS) Pharma major Cipla on Wednesday reported a 54.6 per cent decline in its consolidated net profit for the fourth quarter (Q4) of FY26, weighed down by an impairment charge, while revenue also witnessed a marginal drop on a year-on-year basis.The company posted a consolidated net profit of Rs 554.64 crore in the January-March quarter, compared to Rs 1,221.84 crore reported in the corresponding quarter of the previous financial year (Q4 FY25), according to its stock exchange fi…
Mumbai, April 24 (IANS) The domestic equity markets saw negative performance in early hours on Friday amid elevated geopolitical tensions and the Q4 earnings season.Sensex was trading at 77,263, down 0.51 per cent or 400 points, while Nifty was down 0.41 per cent, or 100 points, in early trade amid panic selling in IT, financial and pharma stocks. However, support was seen in FMCG and chemical scrips.Cipla, Infosys, Dr Reddy’s Laboratories, Sun Pharma, TCS and ICICI Bank were among the top lag…
New Delhi, April 15 (IANS) Healthcare companies in India are expected to deliver high single-digit revenue growth (year-on-year) in the fourth quarter of FY26 (Q4 FY26), a report showed on Wednesday.However, EBITDA margins will materially be corrected, according to the report by Systematix.“Median growth is estimated at 12 per cent for revenue and 3.6 per cent for EBTIDA, with net earnings likely witnessing a 14 per cent decline, the report mentioned.The primary driver of this on-year decline …
Mumbai, April 3 (IANS) Indian equity markets closed lower for the sixth consecutive week amid escalating geopolitical tensions in West Asia and sharp currency fluctuations, with both headline indices ending in the red during a shortened four-day trading week.Sensex ended at 73,319.55 on Thursday, down 263.67 points or 0.35 per cent, compared to the previous Friday’s close. Nifty 50 settled at 22,713.10, a decline of 106.50 points or 0.46 per cent on a week-on-week basis.In the final session of t…
New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).In its latest enforcement report, the US health regulator said that Cipla USA, Inc, based in Warren, New Jersey, is recalling certain batches of Nilotinib Capsules in two strengths — 150 mg and 200 mg.The recall involves 271 cartons of one batch and 164 cartons of another batch of the …
Mumbai, Jan 28 (IANS) Indian equity benchmark indices Sensex and Nifty ended Wednesday’s session with modest gains, managing to stay in the green despite sharp volatility through the day. Investor sentiment was influenced by December-quarter earnings announcements and the finalisation of the India–European Union Free Trade Agreement.The Sensex closed at 82,345, rising 487 points, or 0.60 per cent. During the session, the index moved between a high of 82,504 and a low of 81,815 as markets swu…